AC Immune S.A. ( ACIU) - Key Metrics
ACIU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.15 | $0.02 | $0 | $0 |
| 2026Q1 | $0.01 | -$0.15 | $0 | $0 |
| 2025Q4 | $0 | -$0.14 | -$0.16 | -$0.16 |
| 2025Q3 | $0.01 | -$0.16 | -$0.19 | -$0.19 |
| 2025Q2 | $0.01 | -$0.21 | -$0.16 | -$0.16 |
ACIU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 25.31 |
| 2026Q1 | 0% | -3.66 |
| 2025Q4 | 0% | -4.45 |
| 2025Q3 | 0% | -3.59 |
| 2025Q2 | 0% | -1.92 |
ACIU
Price: $2.49
52 week price:
Earnings Per Share: -0.53 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 182100
Ebitda: -8.8 millionMarket Capitalization: 240.2 million